Scinovex
articleTop 1% cited

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

American Journal of Transplantation · 2010 · Vol. 10(3) · pp. 535–546
Flavio VincentiB CharpentierYves VanrenterghemLionel RostaingBarbara A. BresnahanP. DarjiP. MassariG. Mondragon-RamirezMamta AgarwalG. RussoLin ChenPushkal GargChristian P. Larsen
Renal Transplantation Outcomes and TreatmentsPneumocystis jirovecii pneumonia detection and treatmentOrgan Transplantation Techniques and OutcomesBelataceptMedicineImmunosuppressionUrologyRenal functionCalcineurinKidney transplantationClinical endpointTransplantationRegimen

MeSH terms

AbataceptAdultFemaleGlomerular Filtration RateHumansImmunosuppression TherapyImmunosuppressive AgentsLymphoproliferative DisordersMaleMiddle AgedRisk FactorsTime FactorsIncidenceKidney TransplantationCyclosporine
Citations
936
FWCI
51.90
field-weighted impact
References
48
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.